An Important Check-Up On Maravai LifeSciences Holdings Inc (NASDAQ: MRVI)

Maravai LifeSciences Holdings Inc (MRVI) concluded trading on Wednesday at a closing price of $8.61, with 5.35 million shares of worth about $46.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.15% during that period and on April 3, 2024 the price saw a gain of about 1.18%. Currently the company’s common shares owned by public are about 132.23M shares, out of which, 106.79M shares are available for trading.

Stock saw a price change of 3.24% in past 5 days and over the past one month there was a price change of 13.14%. Year-to-date (YTD), MRVI shares are showing a performance of 31.45% which decreased to -38.54% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.52 but also hit the highest price of $16.62 during that period. The average intraday trading volume for Maravai LifeSciences Holdings Inc shares is 2.71 million. The stock is currently trading 7.67% above its 20-day simple moving average (SMA20), while that difference is up 24.69% for SMA50 and it goes to 3.04% higher than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) currently have 132.23M outstanding shares and institutions hold larger chunk of about 86.17% of that.

The stock has a current market capitalization of $1.14B and its 3Y-monthly beta is at 0.01. It has posted earnings per share of -$0.90 in the same period. It has Quick Ratio of 7.41 while making debt-to-equity ratio of 1.47. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MRVI, volatility over the week remained 4.20% while standing at 6.44% over the month.

Analysts are in expectations that Maravai LifeSciences Holdings Inc (MRVI) stock would likely to be making an EPS of -$0.03 in the current quarter, while forecast for next quarter EPS is -$0.01 and it is $0.05 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.03 which is -$0.02 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.03 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -154.23% while it is estimated to increase by 381.65% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on December 12, 2023 offering a Buy rating for the stock and assigned a target price range of between $10 and $8 to it. Stock get a Neutral rating from UBS on January 05, 2023.

Most Popular

Related Posts